Spacecraft maker Terran Orbital &#x27wanting at anything,&#x27 CEO claims right after Lockheed Martin takeover bid

Spacecraft maker Terran Orbital &#x27wanting at anything,&#x27 CEO claims right after Lockheed Martin takeover bid


Satellite manufacturer Terran Orbital is “hunting at anything” relating to the firm’s potential, CEO Marc Bell explained to CNBC, as it considers Lockheed Martin’s acquisition supply.

“We uncovered out about [Lockheed’s takeover bid] when the rest of the environment discovered out about it,” Bell said on CNBC’s “Manifest House” podcast.

Lockheed’s proposal submitted previous week values Terran Orbital at virtually $600 million, or about a third of its equity valuation from when the firm went public by way of a exclusive goal acquisition business, or SPAC, two a long time in the past. The defense huge is now a significant stakeholder in Terran Orbital, with a 28.3% stake at the time of the proposal.

Terran Orbital declined to remark on a shareholder lawsuit submitted Wednesday in response to the company’s board adopting a “poison tablet” inventory legal rights prepare after Lockheed’s provide.

Indicator up listed here to get weekly editions of CNBC’s Investing in Area newsletter.

Bell emphasised that Lockheed has been “a partner of ours for many decades,” but pointed out that Terran Orbital hired Jefferies in December to lead a strategic critique of its route ahead, with alternatives ranging from new investors to a prospective sale of the business.

“We have had a lot of conversations with lots of people and carry on to run our course of action. We have no deadline to our process, and our goal is to have maximum worth for all of our shareholders,” Bell explained.

Bell added that Terran Orbital is “thrilled with the validation” that Lockheed’s present gave it.

Really do not overlook these stories from CNBC Professional:



Resource

CVS blows past estimates, hikes outlook as insurance business outperforms 
World

CVS blows past estimates, hikes outlook as insurance business outperforms 

A screen displays the logo and trading information for CVS at the New York Stock Exchange, March 24, 2026. Jeenah Moon | Reuters CVS Health on Wednesday blew past first-quarter earnings and revenue estimates and raised its 2026 guidance, as its once-troubled insurance business showed improvement.  CVS, which operates the nation’s largest pharmacy chain, sees […]

Read More
European stocks soar amid growing optimism for Gulf peace deal
World

European stocks soar amid growing optimism for Gulf peace deal

European stocks soared on Wednesday as traders responded to reports that the U.S. and Iran are close to an agreement that will bring an end to the war. The White House expects an Iranian response on “several key points”, including a moratorium on nuclear enrichment, in the next 48 hours, Axios reported. The countries are […]

Read More
Novo Nordisk CEO: Aim is to expand weight-loss market in U.S.
World

Novo Nordisk CEO: Aim is to expand weight-loss market in U.S.

Charlotte Reed speaks with Mike Doustdar, CEO of Novo Nordisk, after the Danish comapny hiked its 2026 full-year guidance on the back of increased expectations for GLP-1 product sales. Source

Read More